Dengue: An Escalating Problem of Our Society

Faiza Naseer^1*, Attiya Nazish¹, Rida Khan², Samra Sadiq¹, Nadia Perveen¹, Zainab Kaleem², Shaneel Kausar², Muhammad Zeeshan Ashraf¹

¹College of Pharmacy, GC University, Faisalabad, Pakistan.
²Department of Physiology and Pharmacology, Agriculture University, Faisalabad, Pakistan.

DOI: 10.4236/ojepi.2015.51002                

Abstract

Dengue virus infection is more and more acknowledged as one of the world’s major escalating problems. Dengue is prevalent in most tropical and subtropical countries. To solve this problem, pharmacists need to understand the epidemiology, risk factors, clinical spectrum, diagnosis, management, prevention, and novel avenues of dengue.

Keywords

Dengue, Escalating, Pharmacist, Prevention, Novel Avenues

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Westaway, E.G. and Blok, J. (1997) Taxonomy and Evolutionary Relationships of Flaviviruses. In: Dengue and Dengue Hemorrhagic Fever, CAB International, London, 147-173.
[2]	Gubler, D.J. (1987) Dengue and Dengue Hemorrhagic Fever in the Americas. Puerto Rico Health Science Journal, 6, 107-111.
[3]	Gubler, D.J. (1997) Dengue and Dengue Hemorrhagic Fever: Its History and Resurgence as a Global Public Health Problem. In: Gubler, D.J. and Kuno, G., Eds., Dengue and Dengue Hemorrhagic Fever, CAB International, London, 1-22.
[4]	Gubler, D.J. (2001) The Global Pandemic of Dengue/Dengue Hemorrhagic Fever: Current Status and Prospects for the Future. Annals, Academy of Medicine, Singapore.
[5]	Gubler, D.J. and Trent, D.W. (1994) Emergence of Epidemic Dengue/Dengue Hemorrhagic Fever as a Public Health Problem in the Americas. Infectious Agents and Disease, 2, 383-393.
[6]	Gubler, D.J. (1996) Arboviruses as Imported Disease Agents: The Need for Increased Awareness. Achieve Virology, 11, 21-32.
[7]	Reiter, P. and Gubler, D.J. (1997) Surveillance and Control of Urban Dengue Vectors. Dengue and Dengue Hemorrhagic fever. United Kingdom: CAB International, London, 425-462.
[8]	WHO (1997) Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. 2nd Edition, World Health Organization, Geneva.
[9]	Guha-Sapir, D. and Schimmer, B. (2005) Dengue Fever: New Paradigms for a Changing Epidemiology. Emerging Themes in Epidemiology, 2. http://dx.doi.org/10.1186/1742-7622-2-1
[10]	Deen, J., et al. (2006) The WHO dengue Classification and Case Definitions: Time for a Reassessment. Lancet, 368, 170-173. http://dx.doi.org/10.1016/S0140-6736(06)69006-5
[11]	Rigau-Perez, J. (2006) Severe Dengue: The Need for New Case Definitions. Lancet Infectious Diseases, 6, 297-302. http://dx.doi.org/10.1016/S1473-3099(06)70465-0
[12]	Bandyopadhyay, S., Lum, L.C. and Kroeger, A. (2006) Classifying Dengue: A Review of the Difficulties in Using the WHO Case Classification for Dengue Haemorrhagic Fever. Tropical Medicine and International Health, 11, 1238-1255. http://dx.doi.org/10.1111/j.1365-3156.2006.01678.x
[13]	Rigau-Perez, J.G., et al. (1998) Dengue and Dengue Haemorrhagic Fever. Lancet, 352, 971-977. http://dx.doi.org/10.1016/S0140-6736(97)12483-7
[14]	Keller, T.H., et al. (2006) Finding New Medicines for Flaviviral Targets. Novartis Foundation Symposium, 277, 102-114. http://dx.doi.org/10.1002/0470058005.ch8